Episode

393: A conversation with the 'godfather' of biotech

Podcast
The Readout Loud
Published
Mar 20, 2026
Duration seconds
2705
Processing state
not_requested
Canonical source
https://traffic.megaphone.fm/TTSAA2542570165.mp3?updated=1774024042
Audio
https://traffic.megaphone.fm/TTSAA2542570165.mp3?updated=1774024042
JSON
/v1/public/podcasts/the-readout-loud-1134305/episodes/393-a-conversation-with-the-godfather-of-biotech
Markdown
/podcast/the-readout-loud-1134305/393-a-conversation-with-the-godfather-of-biotech.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-readout-loud-1134305/episodes/393-a-conversation-with-the-godfather-of-biotech/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-readout-loud-1134305/393-a-conversation-with-the-godfather-of-biotech.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

On this week's episode of "The Readout LOUD," we bring you a special conversation with Stelios Papadapolous, also know as the "godfather" of biotech. He sat down for an on-stage chat with our colleague Damian Garde Thursday afternoon during STAT’s Breakthrough Summit East event in New York City. We also chat about the latest biotech news, including new weight loss data from Structure Therapeutics and Eli Lilly, plus recent staff departures from the Food and Drug Administration.